Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
91
Frequently Asked Questions
What is Market Cap of Medexus Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medexus Pharmaceuticals Inc market cap is $72.26M.
What is the 52-week high for Medexus Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medexus Pharmaceuticals Inc 52 week high is $3.88 as of September 11, 2025.
What is the 52-week low for Medexus Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medexus Pharmaceuticals Inc 52 week low is $1.27 as of September 11, 2025.
What is Medexus Pharmaceuticals Inc stock price today?
Medexus Pharmaceuticals Inc stock price today is $2.25.
What was Medexus Pharmaceuticals Inc stock price yesterday?
Medexus Pharmaceuticals Inc stock price yesterday was $2.24.
What is the PE ratio of Medexus Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medexus Pharmaceuticals Inc’s P/E ratio is 74.17.
What is the Price-to-Book ratio of Medexus Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medexus Pharmaceuticals Inc P/B ratio is 1.3644.
What is the 50-day moving average of Medexus Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medexus Pharmaceuticals Inc 50-day moving average is $2.11.
How many employess does Medexus Pharmaceuticals Inc has?